| NCT ID | NCT06082687 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Central Florida |
| Condition | Tissue |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000,000 participants |
| Start Date | 2022-09-14 |
| Primary Completion | 2027-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000,000 participants in total. It began in 2022-09-14 with a primary completion date of 2027-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Research scientists of the University of Central Florida College of Medicine (COM) and Burnett School of Biomedical Sciences (BSBS) conduct laboratory studies in biomedical and translational medical research for the purpose of understanding human disease and developing innovative methods for diagnosing, measuring, or treating disease or disease symptoms. The key research divisions are cancer, cardiovascular, immunity and pathogenesis, neuroscience, and molecular microbiology.
Eligibility Criteria
Inclusion: \- de-identified human tissue from cooperating institutions for unknown/undisclosed donors.
Frequently Asked Questions
Who can join the NCT06082687 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Tissue. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06082687 currently recruiting?
Yes, NCT06082687 is actively recruiting participants. Visit ClinicalTrials.gov or contact University of Central Florida to inquire about joining.
Where is the NCT06082687 trial being conducted?
This trial is being conducted at Orlando, United States.
Who is sponsoring the NCT06082687 clinical trial?
NCT06082687 is sponsored by University of Central Florida. The trial plans to enroll 1,000,000 participants.